1. Home
  2. Clinical Topics
  3. FDA grants waiver for flu test
Clinical TopicsDrugs and DevicesImmune/Lymphatic SystemInfection PreventionInfectious DiseasesNewsWeb Exclusives

FDA grants waiver for flu test

Share

On January 6, the U.S. Food and Drug Administration (FDA) granted the first waiver to allow a nucleic acid-based test, the Alere i Influenza A & B test, to be used in a greater variety of healthcare settings. The test uses a nasal swab sample from a patient and provides results in as little as 15 minutes. Negative results don’t rule out influenza virus infection. Read more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts